Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q2 FY2027 Earnings Presentation
41 slides from Sunshine's earnings presentation, Nov 2, 2026
Slide 1: 2QFY27 Earnings Webinar
2QFY27 Earnings Webinar Sunshine Holdings PLC 02 November 2026
Slide 2: Housekeeping Announcements
Housekeeping Announcements • The webinar will be recorded and later uploaded to our IR website as well as CSE website for future reference (https://www.sunshineholdings.lk/investor-relations/) • All participants will be muted during the presentation • Participants can use the 'Raise Hand' option to
Slide 3: Agenda
Agenda 01 Corporate Announcements 02 Group Performance 03 Healthcare 04 Consumer 05 Agribusiness 06 Q&A 07 Appendix
Slide 4: Team
Team SUNSHINE HO L DINGS SUNSHINE HEAL T HCAR E Shantha Bandara Dr. Thiru Sayandhan Farman Nizar Eranga Illangasinghe CEO – Sunshine Pharmaceuticals and CEO – Sunshine Medical Devices and Lina COO – Healthguard Pharmacy Sector Financial Controller – Healthcare Healthguard Distribution Manufacturing
Slide 5: Corporate Announcements
Corporate Announcements • 13th October 2026 – Zydus Sunshine Lifesciences, our 50:50 joint venture with India’s Zydus Lifesciences, signed an agreement with the BOI to develop a GMP-compliant oral solid dosage manufacturing facility at the Horana Export Processing Zone. • 16th October 2026 – Sunshin
Slide 6: Group Performance
Group Performance
Slide 7: Group at a glance – 2QFY27
Group at a glance – 2QFY27 Revenue Composition – 2QFY27 LKR 3.6bn LKR 2.3bn LKR 0.74 Agriculture +27.5% YoY +84.7% YoY +80.3% YoY 2.1% EBIT Earnings EPS 12.7% LKR 21.6bn 29.8% 17.9% LKR 10.38 48.5% +7.0 pts YoY +4.2 pts YoY -1.4% YoY Gearing ROE NBV 32.0% Healthcare 38.8% 20.5% Consumer LKR 56.7bn 1
Slide 8: Group – Performance Highlights
Group – Performance Highlights 2QFY27 2QFY26* YoY% 1QFY27 QoQ % Revenue 21,646 16,396 32.0% 18,538 16.8% EBIT 3,628 2,846 27.5% 2,440 48.7% EBIT margin 16.8% 17.4% 13.2% PAT 2,331 1,262 84.7% 1,407 65.6% PAT margin 10.8% 7.7% 7.6% PATMI 1,451 805 80.3% 665 118.0% EPS (LKR) 0.74 0.41 80.3% 0.34 118.0
Slide 9: Movement in Revenue & EBIT
Movement in Revenue & EBIT Revenue Movement [LKR Million] EBIT Movement [LKR Million] 6 66 3,628 3,406 56 21,646 351 359 1,788 16,396 2,846 2QFY26 Healthcare Consumer Agri 2QFY27 2QFY26 Healthcare Consumer Agri Other 2QFY27 Revenue Composition – Revenue QoQ 25.0 20.0 13% 15% Revenue LKR bn 13% 13% 1
Slide 10: Healthcare
Healthcare
Slide 11: Sunshine Healthcare Lanka: integrated healthcare company
Sunshine Healthcare Lanka is Sri Lanka’s only fully integrated healthcare company encompassing the entire pharma value chain Government and Local market Manufacturing and R&D Revenue Split 2QFY27 Pharma Manufacturing, Sri Lanka’s first facility for Respiratory Care 13% Capsules Tablets Nasal Spray D
Slide 12: Healthcare Sector – Highlights
Healthcare Sector – Highlights Sector Highlights 10,348 10,502 9,756 9,129 Sector revenue grew 20.5% YoY in 2QFY27, driven by strong 8,714 growth in the medical devices, pharmaceutical manufacturing and distribution businesses. Sector EBIT margin improved to 13.5% in 2QFY27, although price reduction
Slide 13: Sunshine Pharmaceuticals – Performance Highlights
Sunshine Pharmaceuticals – Performance Highlights Business Highlights 8,877 The pharmaceutical segment’s revenue declined by 27.4% YoY in 6,444 2QFY27, mainly due to the high base in 2QFY26 following a one-off change in the business model, coupled with price reductions and 4,730 4,202 supply-side ch
Slide 14: Healthguard Distribution – Performance Highlights
Healthguard Distribution – Performance Highlights Business Highlights 6,549 The Distribution segment’s revenue grew by 8.5% YoY in 2QFY27, 6,397 driven by a volume growth of 8.9%. 5,969 Growth was supported by higher volumes from key principals, 5,894 5,852 despite stock-outs arising from regulatory
Slide 15: Sunshine Medical Devices – Performance Highlights
Sunshine Medical Devices – Performance Highlights Business Highlights 1,623 1,453 1,464 1,360 The Medical Devices segment recorded a 31.2% YoY revenue 1,237 growth in 2QFY27, reflecting strong performance in both private and government segments during the quarter. 2QFY26 3QFY26 4QFY26 1QFY27 2QFY27
Slide 16: Lina Manufacturing – Performance Highlights
Lina Manufacturing – Performance Highlights Business Highlights 1,390 1,174 During 2QFY27, revenue from the manufacturing business recorded 1,093 a robust growth of 49.3% YoY, primarily driven by government 931 895 product deliveries in line with the calendar year 2026 requirements. MDI capacity uti
Slide 17: Healthguard Pharmacy – Performance Highlights
Healthguard Pharmacy – Performance Highlights Business Highlights 762 756 752 753 The Retail segment, Healthguard Pharmacy, recorded a flat revenue performance with a 0.1% YoY growth in 2QFY27, as price increase was offset by volume decline, mainly in the wellness range. 729 2QFY26 3QFY26 4QFY26 1QF
Slide 18: Consumer Sector
Consumer Sector
Slide 19: Sunshine Consumer, market leader in branded tea, confectionery and cinnamon
Sunshine Consumer, market leader in branded tea, confectionery and organic Ceylon cinnamon exports Tea Brand Portfolio Revenue Split 2QFY27 Largest branded tea company in Sri Lanka – 49.0% General Trade Inter Co. / market share. *Pepper Cube Sep 2026, Shares are 3 months average for end period Other
Slide 20: Consumer Sector – Highlights
Consumer Sector – Highlights Sector Highlights 8,388 Consumer sector revenue grew 68.4% YoY to LKR 8.4 Bn in 6,597 2QFY27, covering our tea and confectionery brands and tea and spice exports.. 4,983 4,732 4,542 Growth was mainly driven by the consolidation of JAPC, our cinnamon export business. Excl
Slide 21: Tea Brands – Performance Highlights
Tea Brands – Performance Highlights 2,725 2,721 Business Highlights 2,650 Revenue from the Branded Tea business grew by 3.4% YoY to LKR 2,631 2.7 Bn in 2QFY27, supported by growth in the general trade channel. 2,464 Watawala Thei remained the key volume contributor, while Ran Kahata recorded the str
Slide 22: Confectionery Brands – Performance Highlights
Confectionery Brands – Performance Highlights Business Highlights 565 557 544 Revenue from the Confectionery business declined by 2.2% YoY in 530 2QFY27, mainly due to lower sales in the Toffee/Candy category, partly offset by strong growth in the Gums and Wafers categories. 476 2QFY26 3QFY26 4QFY26
Slide 23: Tea Exports – Performance Highlights
Tea Exports – Performance Highlights Business Highlights 2,975 USD 8.6 Mn The export business recorded a revenue growth of 60.8% YoY in 2QFY27 to reach LKR 3.0 Bn, mainly driven by incremental business 1,936 1,850 from existing customers and higher sales of value-added products. 1,628 1,452 2QFY26 3
Slide 24: Spice Exports – Performance Highlights
Spice Exports – Performance Highlights Business Highlights 2,239 USD 6.6 Mn The spice export business recorded a revenue growth of 45.7% YoY 1,713 in 2QFY27 to reach LKR 2.2 Bn, mainly driven by improved pricing 1,536 and a favourable product mix. Sales volume improved by 11.0% YoY driven by higher
Slide 25: Agribusiness
Agribusiness
Slide 26: Watawala Plantations PLC: palm oil and dairy farming
Watawala Plantations PLC primarily engages in palm oil and dairy farming Palm Oil Revenue Split 2QFY27 A land extent of ~3,400 Ha under palm oil cultivation Diary, 11% The first in South Asia to receive RSPO certification for sustainable oil palm plantation Positioning – largest oil palm cultivator
Slide 27: Agribusiness – Highlights
Agribusiness – Highlights 2,809 Sector Highlights 2,698 2,754 The Agribusiness sector reported revenue of LKR 2.8 Bn in 2,078 2QFY27, reflecting a 2.1% YoY improvement, driven by the 2,175 performance of the palm oil business. 1,336 The dairy business also showed an improvement, with its losses 1,32
Slide 28: Palm Oil – Performance Highlights
Palm Oil – Performance Highlights Business Highlights 2,550 2,451 2,340 The Palm Oil segment recorded 4.8% YoY improvement in revenue in 2QFY27, driven by favourable pricing, which offset lower sales 1,922 volumes due to reduced bought crop availability and lower oil 1,930 extraction rates. 1,361 1,
Slide 29: Dairy – Performance Highlights
Dairy – Performance Highlights Business Highlights 300 265 302 245 259 The dairy business recorded a 0.8% YoY growth in revenue in 2QFY27, supported by a higher average milk selling price despite lower milk sales volumes. The EBIT loss narrowed to LKR 26 Mn compared to LKR 40 Mn in (40) 2QFY26, supp
Slide 30: Q&A
Q&A
Slide 31: Appendix
Appendix
Slide 32: Investment in Digital Health (Doc990)
Investment in Digital Health (Doc990) Transaction Overview About Doc990 • Digital Health (Private) Limited operates Doc990, an integrated digital healthcare platform in Sri Lanka, launched in 2016 21.92% LKR 410.8 Mn 16 Oct 2026 • Connects patients, doctors, hospitals and corporates through mobile a
Slide 33: Key ratios – 2QFY27
Key ratios – 2QFY27 INVESTOR RATIOS PROFITABILITY RATIOS 2QFY27 2QFY26 2QFY27 2QFY26 LKR 1.87 LKR 1.42 29.1% 32.1% EPS TTM EPS TTM 17.88% 13.65% GP Margin GP Margin ROE ROE 16.8% 17.4% 15.41 22.84 EBIT Margin EBIT Margin PER TTM PER TTM 10.38 10.53 NAV NAV 10.8% 7.7% 2.77 3.09 PAT Margin PAT Margin
Slide 34: Sunshine Pharmaceuticals – Market Dynamics
Sunshine Pharmaceuticals – Market Dynamics During 2Q IQVIA, the market experienced a growth of 7.0% (2Q 2026 MAT YoY %) 11.6% 10.2% 10.1% 10.1% 10.0% 9.3% 8.7% 8.9% 7.6% 8.2% 6.7% 4.8% 3.8% 3.1% 2.2% 2.1% 1.3% -1.1% -2.4% -4.2% -5.3% -7.3% 2QFY26 3QFY26 4QFY26 1QFY27 2QFY27 RD Value Growth YoY RD Vo
Slide 35: Sunshine Medical Devices – Market Dynamics
Sunshine Medical Devices – Market Dynamics 100% 91% 89% 88% 88% 86% 90% 90% 86% 86% 81% 85% 81% 84% 84% 81% 77% 79% 79% 79% 77% 76% 73% 75% 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 2QFY27 Hospital Occupancy Lab Tests Operation Theaters Source – Management Information
Slide 36: Brand Value Market Share (%) – Tea
Brand Value Market Share (%) – Tea 100.0 90.0 28 28 30 27 27 27 28 28 27 27 29 29 28 29 28 29 28 29 29 28 28 29 27 28 27 28 28 29 28 32 31 80.0 70.0 6 6 6 5 5 5 5 5 5 5 5 5 5 6 6 6 6 6 6 6 8 7 7 6 5 4 5 6 6 6 6 60.0 50.0 47 47 48 48 49 49 49 48 48 48 48 50 48 47 48 48 48 50 40.0 45 46 44 45 47 49 47
Slide 37: Brand Value Market Share (%) – Confectionary
Brand Value Market Share (%) – Confectionary 100 90 23 23 22 21.6 21 21.3 20.3 20.1 19.6 24 24 25 25 25 26 25 24 24 80 15 14.5 14.4 13.8 14.1 70 15.4 13.0 14.0 14.9 14.9 14.7 14.4 14.5 15.1 14.2 13.0 13.3 13.7 60 50 38 38.8 38.7 39 36.7 35.6 37.2 36.1 36.4 36.2 36.4 37.2 38.1 37.5 38.3 37.1 35.6 36.
Slide 38: Price Index – Tea and Confectionary
Price Index – Tea and Confectionary Tea Price Index Confectionery Price Index 110 110 107 107 107 107 107 107 107 107 107 100 105 100 98 105 100 100 100 100 100 100 100 100 100 100 100 104 103 103 100 100 100 100 100 100 100 100 100 100 100 100 102 100 101 101 101 101 90 100 85 99 99 81 81 95 96 80
Slide 39: Agribusiness – Price Movement
Agribusiness – Price Movement Settlement Price (RM) WDL's Avg Milk Price (LKR) 5,000 260 4,835 255 255 4,800 250 4,600 245 MALAYSIAN RINGGITS – RM 4,400 240 4,443 235 4,200 230 229 4,000 225 220 3,800 215 3,600 210 3,400 205 March-25 June-25 September-25 December-25 March-26 June-26 September-26 Sou
Slide 40: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 41: Thank you!
Thank you! For more information, Please visit our Investor Relations page https://www.sunshineholdings.lk/investor-relations/